Kure Kyosai Hospital
Hiroshima, Japan
General hospital in Kure
2 Chome-3-番28号 Nishichuo, Kure, Hiroshima 737-8505
About Kure Kyosai Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Actelion
3
Janssen Research & Development, LLC
2
Clinical Trials at Kure Kyosai Hospital
During the past decade, Kure Kyosai Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
2019-07-29
2024-09-24
Active, not recruiting
187
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
2019-09-26
2029-09-29
Active, not recruiting
1,064
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
2020-07-07
2026-08-07
Recruiting
230
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
2020-06-30
2026-09-21
Recruiting
900
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
2022-01-19
2025-08-14
Recruiting
318
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kure Kyosai Hospital
According to Clinical.Site data, the most researched conditions in "Kure Kyosai Hospital" are
"Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Crohn Disease" (1 trials), "Pulmonary Arterial Hypertension" (1 trials), "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Kure Kyosai Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kure Kyosai Hospital
Most popular intervention types in "Kure Kyosai Hospital" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Macitentan 10 mg" (2 trials), "FDC macitentan/tadalafil" (1 trials), "Guselkumab" (1 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kure Kyosai Hospital
The vast majority of trials in "Kure Kyosai Hospital" are
5 trials for "All" genders.
Clinical Trials Status at Kure Kyosai Hospital
Currently, there are NaN active trials in "Kure Kyosai Hospital".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Kure Kyosai Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kure Kyosai Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".